HomeINFIQ • OTCMKTS
add
Infinity Pharmaceuticals Inc.
Previous close
$0.00
Day range
$0.00 - $0.00
Market cap
54.46 USD
Avg Volume
5.12K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Reuters
20 hours ago
Dow and S&P end at fresh record highs, lifted by Netflix earnings and tech
stocks
0.085%
0.40%
11.09%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2023info | Y/Y change |
|---|---|---|
Revenue | 583.00K | — |
Operating expense | 3.75M | — |
Net income | -9.96M | — |
Net profit margin | -1.71K | — |
Earnings per share | — | — |
EBITDA | -10.01M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.75M | — |
Total assets | 21.23M | — |
Total liabilities | 58.64M | — |
Total equity | -37.41M | — |
Shares outstanding | 90.76M | — |
Price to book | -0.00 | — |
Return on assets | -98.86% | — |
Return on capital | -160.14% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2023info | Y/Y change |
|---|---|---|
Net income | -9.96M | — |
Cash from operations | -8.01M | — |
Cash from investing | — | — |
Cash from financing | 16.00K | — |
Net change in cash | -7.99M | — |
Free cash flow | -4.12M | — |
About
Founded
1995
Headquarters
Website
Employees
30
